Synthesis, Physicochemical Properties and Molecular Docking of New Benzothiazole Derivatives As Antimicrobial Agents Targeting DHPS Enzyme

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2022 Dec 23

PMID 36551457

Authors

Rasha A Azzam

Heba A Elboshi

Galal H Elgemeie

Affiliations

Soon will be listed here.

Abstract

The drug-resistance problem is widely spread and becoming more common in community-acquired and nosocomial strains of bacteria. Therefore, finding new antimicrobial agents remains an important drug target. From this perspective, new derivatives of benzothiazole were synthesized and evaluated for their antimicrobial activity and ability to inhibit the DHPS enzyme. The synthesis was carried out by the reaction of benzothiazole -arylsulphonylhydrazone with -aryl-2-cyano-3-(dimethylamino)acrylamide, -aryl-3-(dimethylamino)prop-2-en-1-one, arylaldehydes or diazonium salt of arylamine derivatives, which led to the formation of -arylsulfonylpyridones (yield 60-70%) and - (yield 50-60%)-(2-(benzo[]thiazole-2-yl)-3-arylacryloyl-4-methylsulfonohydrazide - (yield 60-65%) 4-(benzo[]thiazole-2-yl)-5-aryl-1-pyrazol-3(2)-one - (yield 65-75%), and -(2-(benzo[]thiazol-2-yl)-2-(2-arylhydrazono)acetyl)-4-arylsulfonohydrazide - (yield 85-70%). The antimicrobial evaluations resulted into a variety of microbial activities against the tested strains. Most compounds showed antimicrobial activity against with an MIC range of 0.025 to 2.609 mM. The most active compound, , exhibited superior activity against the strain with an of MIC 0.025 mM among all tested compounds, outperforming both standard drugs ampicillin and sulfadiazine. The physicochemical-pharmacokinetic properties of the synthesized compounds were studied, and it was discovered that some compounds do not violate rule of five and have good bioavailability and drug-likeness scores. The five antimicrobial potent compounds with good physicochemical-pharmacokinetic properties were then examined for their inhibition of DHPS enzyme. According to the finding, three compounds, -, had IC values comparable to the standard drug and revealed that compound was the most active compound with an IC value of 7.85 μg/mL, which is comparable to that of sulfadiazine (standard drug) with an IC value of 7.13 μg/mL. A docking study was performed to better understand the interaction of potent compounds with the binding sites of the DHPS enzyme, which revealed that compounds - are linked by two arene-H interactions with Lys220 within the PABA pocket.

Citing Articles

Synthesis, antibacterial evaluation and in silico studies of novel 2-(benzo[d]thiazol-2-yl)-N-arylacetamides and their derivatives as potential DHFR inhibitors.

Metwally N, Elgemeie G, Abdelrazek A, Eldaly S BMC Chem. 2025; 19(1):29.

PMID: 39891220 PMC: 11784096. DOI: 10.1186/s13065-025-01386-5.

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives.

Ismail T, El-Khazragy N, Azzam R RSC Adv. 2024; 14(23):16332-16348.

PMID: 38769969 PMC: 11103668. DOI: 10.1039/d4ra01874e.

Crystal structure of 2-{[5-(methyl-sulfan-yl)-4-phenyl-4-1,2,4-triazol-3-yl]meth-yl}benzo[]thia-zole.

Azzam R, Elgemeie G, Elboshi H, Jones P Acta Crystallogr E Crystallogr Commun. 2023; 79(Pt 9):817-820.

PMID: 37693680 PMC: 10483567. DOI: 10.1107/S2056989023007041.

Novel Fluorescent Benzothiazolyl-Coumarin Hybrids as Anti-SARS-COVID-2 Agents Supported by Molecular Docking Studies: Design, Synthesis, X-ray Crystal Structures, DFT, and TD-DFT/PCM Calculations.

Abdallah A, Abdel-Latif S, Elgemeie G ACS Omega. 2023; 8(22):19587-19602.

PMID: 37284548 PMC: 10237303. DOI: 10.1021/acsomega.3c01085.

Crystal structure of -[3-(benzo[]thia-zol-2-yl)-6-bromo-2-chromen-2-yl-idene]-4-methyl-benzenamine.

Abdallah A, Elgemeie G, Jones P Acta Crystallogr E Crystallogr Commun. 2023; 79(Pt 5):441-445.

PMID: 37151827 PMC: 10162085. DOI: 10.1107/S2056989023002979.

References

Bondock S, Fadaly W, Metwally M . Synthesis and antimicrobial activity of some new thiazole, thiophene and pyrazole derivatives containing benzothiazole moiety. Eur J Med Chem. 2010; 45(9):3692-701. DOI: 10.1016/j.ejmech.2010.05.018. View

Azzam R, Elsayed R, Elgemeie G . Design and Synthesis of a New Class of Pyridine-Based -Sulfonamides Exhibiting Antiviral, Antimicrobial, and Enzyme Inhibition Characteristics. ACS Omega. 2020; 5(40):26182-26194. PMC: 7557949. DOI: 10.1021/acsomega.0c03773. View

Veber D, Johnson S, Cheng H, Smith B, Ward K, Kopple K . Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002; 45(12):2615-23. DOI: 10.1021/jm020017n. View

Li Q, Mitscher L, Shen L . The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors. Med Res Rev. 2000; 20(4):231-93. DOI: 10.1002/1098-1128(200007)20:4<231::aid-med1>3.0.co;2-n. View

Zhao Z, Wolkenberg S, Sanderson P, Lu M, Munshi V, Moyer G . Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bioorg Med Chem Lett. 2007; 18(2):554-9. DOI: 10.1016/j.bmcl.2007.11.085. View

Desai N, Rajpara K, Joshi V . Synthesis of pyrazole encompassing 2-pyridone derivatives as antibacterial agents. Bioorg Med Chem Lett. 2013; 23(9):2714-7. DOI: 10.1016/j.bmcl.2013.02.077. View

Tasler S, Muller O, Wieber T, Herz T, Pegoraro S, Saeb W . Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization. Bioorg Med Chem. 2009; 17(18):6728-37. DOI: 10.1016/j.bmc.2009.07.047. View

Lee Y, Jin G, Lee S, Park J, Ryu J, Jeon R . Inhibition of TNF-α-mediated inflammatory responses by a benzodioxolylacetylamino-linked benzothiazole analog in human fibroblast-like synoviocytes. Biochem Biophys Res Commun. 2011; 408(4):625-9. DOI: 10.1016/j.bbrc.2011.04.073. View

Ke S, Wei Y, Yang Z, Wang K, Liang Y, Shi L . Novel cycloalkylthiophene-imine derivatives bearing benzothiazole scaffold: synthesis, characterization and antiviral activity evaluation. Bioorg Med Chem Lett. 2013; 23(18):5131-4. DOI: 10.1016/j.bmcl.2013.07.023. View

10.

Chakraborty M, Jin K, Brewer 3rd S, Peng H, Platz M, Novak M . Indirect and direct detection of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model anti-tumor drug. Org Lett. 2009; 11(21):4862-5. PMC: 2783571. DOI: 10.1021/ol901959z. View

11.

Vinnicombe H, Derrick J . Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition. Biochem Biophys Res Commun. 1999; 258(3):752-7. DOI: 10.1006/bbrc.1999.0695. View

12.

Mortimer C, Wells G, Crochard J, Stone E, Bradshaw T, Stevens M . Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J Med Chem. 2006; 49(1):179-85. DOI: 10.1021/jm050942k. View

13.

Konig J, Wyllie S, Wells G, Stevens M, Wyatt P, Fairlamb A . Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism. J Biol Chem. 2011; 286(10):8523-8533. PMC: 3048735. DOI: 10.1074/jbc.M110.214833. View

14.

Nurjadi D, Zizmann E, Chanthalangsy Q, Heeg K, Boutin S . Integrative Analysis of Whole Genome Sequencing and Phenotypic Resistance Toward Prediction of Trimethoprim-Sulfamethoxazole Resistance in . Front Microbiol. 2021; 11:607842. PMC: 7840696. DOI: 10.3389/fmicb.2020.607842. View

15.

Bano S, Javed K, Ahmad S, Rathish I, Singh S, Alam M . Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem. 2011; 46(12):5763-8. DOI: 10.1016/j.ejmech.2011.08.015. View

16.

Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

17.

Khedr M, Zaghary W, Elsherif G, Azzam R, Elgemeie G . Purine analogs: synthesis, evaluation and molecular dynamics of pyrazolopyrimidines based benzothiazole as anticancer and antimicrobial CDK inhibitors. Nucleosides Nucleotides Nucleic Acids. 2022; 42(1):77-104. DOI: 10.1080/15257770.2022.2109169. View

18.

Lipinski C . Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2014; 1(4):337-41. DOI: 10.1016/j.ddtec.2004.11.007. View

19.

Catalano A, Rosato A, Salvagno L, Iacopetta D, Ceramella J, Fracchiolla G . Benzothiazole-Containing Analogues of Triclocarban with Potent Antibacterial Activity. Antibiotics (Basel). 2021; 10(7). PMC: 8300675. DOI: 10.3390/antibiotics10070803. View

20.

Al-Tel T, Al-Qawasmeh R, Zaarour R . Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs. Eur J Med Chem. 2011; 46(5):1874-81. DOI: 10.1016/j.ejmech.2011.02.051. View